Skip to content

Clinical trials

Phase 3 Anemia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 3 Country / region: Netherlands Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20062
20082
20091
20131
20142
20151
20163
20191
20212
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting5
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Hoffmann-La Roche4
Agios Pharmaceuticals, Inc.2
Amgen2
CTI BioPharma2
Celgene2
GlaxoSmithKline2
Astellas Pharma Europe B.V.1
Astellas Pharma Global Development, Inc.1
Celgene Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia25
Myelodysplastic Syndromes5
Hematologic Diseases4
Renal Insufficiency, Chronic4
Hemoglobinuria, Paroxysmal3
Primary Myelofibrosis3
Anemia, Diamond-Blackfan2
Bone Marrow Diseases2
Metabolic Diseases2
Myeloproliferative Disorders2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.